STATE STREET CORP - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 21 filers reported holding ARIDIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 8.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$44,474
+227.4%
202,247
+367.7%
0.00%
Q1 2023$13,584
-86.7%
43,247
-50.0%
0.00%
Q4 2022$102,062
+155.2%
86,494
+100.0%
0.00%
Q3 2022$40,000
+29.0%
43,247
+54.2%
0.00%
Q2 2022$31,000
-34.0%
28,047
+6.0%
0.00%
Q1 2022$47,000
-24.2%
26,4470.0%0.00%
Q4 2021$62,000
-36.1%
26,4470.0%0.00%
Q3 2021$97,00026,4470.00%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 347,517$1,279,0001.69%
AIGH Capital Management LLC 150,591$554,0000.12%
ARMISTICE CAPITAL, LLC 1,068,444$3,932,0000.07%
PERRITT CAPITAL MANAGEMENT INC 16,000$59,0000.03%
Minot Wealth Management LLC 25,000$92,0000.02%
Wealth Architects, LLC 14,077$52,0000.01%
TCI Wealth Advisors, Inc. 100$00.00%
FMR LLC 600$2,0000.00%
WELLS FARGO & COMPANY/MN 1,271$4,0000.00%
NORTHERN TRUST CORP 16,572$61,0000.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders